SAT-474 Giant Prolactinoma Case Series Assessing Response on Initial Dose of Cabergoline

Background: Giant prolactinomas (GPs) are rare representing 2-3% of prolactinomas and only ~ 0.5% of all pituitary tumors. Various definitions have been proposed for GP but commonly accepted criteria is tumor dimension of ≥4 cm. GP is often associated with very high prolactin (PRL) ranging 1,000 -10...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Endocr Soc
Hlavní autoři: Madan Paramasivan, Ameena, Marouf, Sarah, Raghunathan, Sapna, Shoakazemi, Alireza, Pollock, Jonathan, Chawda, Sanjiv, Stojanovic, Nemanja, Drincic, Andjela
Médium: Artigo
Jazyk:Inglês
Vydáno: Endocrine Society 2019
Témata:
Neuroendocrinology and Pituitary
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6552231/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-474
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky